Skip to main content
Caplight Logo









Bloodbuy

Bloodbuy

Private
Dallas, TexasHealthcare & Life Scienceshttps://bloodbuy.com

Last Round

Strategic

Jul 23, 2020

Total Funding Raised

$3.75M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Bloodbuy operates in Healthcare & Life Sciences and is based in Dallas, Texas. Its latest recorded funding round was a Strategic round in July 2020.

Bloodbuy is a healthcare technology company that provides a cloud-based marketplace platform to facilitate the distribution and management of blood products between hospitals and blood centers.

Sector

Healthcare & Life Sciences

Verticals

Supply Chain, Healthcare Analytics, Business Intelligence, Pharma Supply Chain, Workflow Automation

Business Model

B2B

Customer Profile

Marketplace Commission

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Bloodbuy Comparables

Compare Bloodbuy with similar companies based on industry and business-model similarity.

Bloodbuy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioMarketplace
82%
Sigma Blood Systems
74%
Lytus Technologies Holdings PTV. Ltd.
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Bloodbuy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 23, 2020
StrategicFeb 17, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 32% MoM.

  • Nov 8, 2025

    Monthly visitors grew 65% MoM, from 482 to 797.

Book a demo to see all signals

For institutional investors. Book with your work email.

Bloodbuy Filings

Explore SEC and related filing metadata, where available.

Bloodbuy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Bloodbuy's valuation, stock price, and market status.

Is Bloodbuy a public or private company?

Bloodbuy is a private company.

What is the current stock price of Bloodbuy?

Bloodbuy is a private company, so its shares have no public market price. Caplight tracks Bloodbuy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Bloodbuy worth (valuation)?

Valuation information for Bloodbuy is not publicly available.

Can I buy Bloodbuy stock?

Bloodbuy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Bloodbuy's last funding round?

Bloodbuy's most recent funding round was Strategic on July 23, 2020.

Who are the main investors in Bloodbuy?

Investor information for Bloodbuy is not publicly disclosed.

Will Bloodbuy IPO soon?

No public IPO plans have been announced for Bloodbuy.

How can I track Bloodbuy secondary market activity?

Caplight tracks bids, offers, and trades in Bloodbuy's shares on secondary markets.

Firmographic Details

HeadquartersDallas, Texas
Employee Range8
Year Founded2014
Last FundingJul 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?